Additionally, it has been observed that pancreatic cancer patients with diabetes have high levels of interleukin-1β and tumor necrosis factor (TNF)-α in the tumor microenvironment [91], which may help to explain the compromised beta-cell function seen in these patients [92]. The gene discussed is TNF; the disease is familial pancreatic carcinoma.